Compare · CAI vs HUM
CAI vs HUM
Side-by-side comparison of Caris Life Sciences Inc. (CAI) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAI and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $48.40B, about 49.8x CAI ($971.9M).
- HUM has been more active in the news (7 items in the past 4 weeks vs 4 for CAI).
- HUM has more recent analyst coverage (25 ratings vs 15 for CAI).
- Company
- Caris Life Sciences Inc.
- Humana Inc.
- Price
- -
- -
- Market cap
- $971.9M
- $48.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2025
- News (4w)
- 4
- 7
- Recent ratings
- 15
- 25
Caris Life Sciences Inc.
CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. The company leases, re-leases, and disposes equipment; and contracts for the repair, repositioning, and storage of equipment. It leases its container equipment to lessees under long-term, short-term, and finance leases. The company also sells containers; and manages equipment for to third-party investors, as well as sells used containers. As of December 31, 2020, it had a container fleet comprised 1,798,520 cost equivalent units. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest CAI
- Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect
- Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
- Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
- SEC Form 144 filed by Caris Life Sciences Inc.
- Director Castleman Peter M was granted 13,192 shares, increasing direct ownership by 82% to 29,321 units (SEC Form 4)
- Director Phillips T Danny was granted 13,192 shares, increasing direct ownership by 11% to 133,060 units (SEC Form 4)
- Director Minor Lloyd was granted 13,192 shares, increasing direct ownership by 71% to 31,813 units (SEC Form 4)
- Director Gilliam Joseph E was granted 13,192 shares, increasing direct ownership by 82% to 29,321 units (SEC Form 4)
- Director Fredrickson David Paul was granted 13,192 shares, increasing direct ownership by 71% to 31,813 units (SEC Form 4)
- Director Vacirca Jeff L was granted 13,192 shares, increasing direct ownership by 27% to 62,863 units (SEC Form 4)
Latest HUM
- Chief Medical Officer Nundy Shantanu was granted 2,549 units of Humana Common (SEC Form 4)
- Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition
- Humana Board Declares Payment of Quarterly Dividend to Stockholders
- Humana Foundation Names 2026 Scholarship Recipients
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- New insider Nundy Shantanu claimed no ownership of stock in the company (SEC Form 3)
- Humana Names Dr. Shantanu Nundy as Chief Medical Officer
- James P. Holland to Join Humana as Medicaid President
- Humana upgraded by Morgan Stanley with a new price target
- Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin